Andrew I. Ritchie

机构：Lung Institute, AstraZeneca (Netherlands), AstraZeneca (Switzerland), Imperial College London

发表论文 68 篇 · 总被引 2514 次 · h-index 20

代表论文

• Lung-function trajectories: relevance and implementation in clinical practice (2024 · The Lancet · 被引 132)
• Structural Predictors of Lung Function Decline in Young Smokers with Normal Spirometry (2024 · American Journal of Respiratory and Critical Care Medicine · 被引 58)
• Respiratory Syncytial Virus–related Community Chronic Obstructive Pulmonary Disease Exacerbations and Novel Diagnostics: A Binational Prospective Cohort Study (2024 · American Journal of Respiratory and Critical Care Medicine · 被引 33)
• Prevalence and Clinical Correlates of Radiologically Detected Coronary Artery Disease in Chronic Obstructive Pulmonary Disease: A Cross-Sectional Observational Study (2024 · American Journal of Respiratory and Critical Care Medicine · 被引 16)
• Select Airway Specialized Proresolving Mediators Are Associated with Recovery from Nonviral Chronic Obstructive Pulmonary Disease Exacerbations (2025 · American Journal of Respiratory and Critical Care Medicine · 被引 9)
• Selected updates on chronic obstructive pulmonary disease (2023 · Current Opinion in Pulmonary Medicine · 被引 7)